CClinicalTrials.gg
CompletedNCT06906718ChariteBerAN6VUpdated Apr 2, 2025

Evaluation of Long-term Visual Acuity Data After Bilateral Implantation of the Aspheric EDOF Lens ACUNEX® Vario

An interventional study of Implantation of an intraocular lens in Intraocular Lens, sponsored by Teleon Surgical B.V.. Completed at 1 site in Germany. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2025-04-02.

Sponsored by Teleon Surgical B.V. · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Feb 2024, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
30 Years and older
Sex
All
01

Study summary

The aim of the ACUNEX® Vario study was to confirm long-term data on the visual quality and contrast sensitivity of an existing EDOF-IOL, which bears the CE mark and has been on the market since 2019.

Read the detailed description

The monocentric, retro-prospective, uncontrolled clinical study following Art. 82 MDR, §§ 47 MPDG and conducted according ISO 14155 shall confirm the long-term safety and performance of the AN6V - ACUNEX® Vario EDOF-IOL which has been marketed since 2019. This IOL model is designed to provide good distance and intermediate vision.

02

Conditions studied

  • Intraocular Lens
03

In context

Lead sponsor

Teleon Surgical B.V. is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Successful bilateral IOL implantation into the capsular bag with at least 12 months follow-up.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Other
    AN6V Recipients

    Single arm recipients of the IOL

    Device: Implantation of an intraocular lens

Interventions

  • DeviceImplantation of an intraocular lens

    Successful bilateral IOL implantation into the capsular bag with at least 12 months follow-up.

06

What researchers measure

Primary outcomes

  1. Visual Acuity

    Visual Acuity at far and intermediate distance.

    Time frame: 12 months

07

Study locations

1 site
  • Charité University Berlin
    Berlin, 10117, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06906718
Lead sponsor
Teleon Surgical B.V.
Collaborators
Charite University, Berlin, Germany
Responsible party
Sponsor
First posted
Apr 2, 2025
Start date
Feb 1, 2024
Primary completion
Aug 29, 2024
Completion
Aug 29, 2024
Last update
Apr 2, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion